CHF-1024
Pharmaceutical compound
From Wikipedia, the free encyclopedia
CHF-1024, also known as 5,6-dihydroxy-2-methylaminotetralin, is a dopamine D2 receptor agonist and α2-adrenergic receptor agonist of the 2-aminotetralin family.[1][2] It is a cyclized phenethylamine analogue of the neurotransmitter dopamine.[1] The drug is the active form of nolomirole (CHF-1035), a prodrug of CHF-1024 and the N,N-diisobutyryl diester of the compound.[1][2] Nolomirole was investigated for the treatment of heart failure but was never marketed.[1][2]
Other namesCHF1024; 5,6-Dihydroxy-2-methylaminotetralin
ATC code
- None
| Clinical data | |
|---|---|
| Other names | CHF1024; 5,6-Dihydroxy-2-methylaminotetralin |
| Drug class | Dopamine D2 recpetor agonist; α2-Adrenergic receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C11H15NO2 |
| Molar mass | 193.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |